Health Logic Interactive Inc. (CHYPF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 40.44 Thousand USD | 1028.09% |
| 2022 | 3585.00 USD | 26.49% |
| 2021 | 2834.30 USD | -99.01% |
| 2020 | 286.88 Thousand USD | 744.77% |
| 2019 | 33.96 Thousand USD | -65.35% |
| 2018 | 98 Thousand CAD | -35.34% |
| 2017 | 151.56 Thousand CAD | 564.61% |
| 2016 | 22.8 Thousand CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | 25 Thousand CAD | -93.61% |
| 2013 | 391 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 41.33 Thousand USD | 2.21% |
| 2024 Q2 | 58.39 Thousand CAD | 41.26% |
| 2023 Q2 | 38.91 Thousand USD | 1368.08% |
| 2023 Q1 | 2650.75 USD | -26.06% |
| 2023 Q4 | 40.44 Thousand USD | 6.51% |
| 2023 FY | 40.44 Thousand USD | 1028.09% |
| 2023 Q3 | 37.97 Thousand USD | -2.43% |
| 2022 FY | 3585.00 USD | 26.49% |
| 2022 Q4 | 3585.00 USD | 38.39% |
| 2022 Q2 | 2783.64 CAD | -2.84% |
| 2022 Q3 | 2590.52 USD | -6.94% |
| 2022 Q1 | 2865.13 CAD | 1.09% |
| 2021 Q2 | 23.82 Thousand CAD | -95.72% |
| 2021 Q3 | 461.09 Thousand CAD | 1835.51% |
| 2021 Q4 | 2834.30 CAD | -99.39% |
| 2021 Q1 | 556.88 Thousand CAD | 52.37% |
| 2021 FY | 2834.30 USD | -99.01% |
| 2020 Q3 | 233.38 Thousand CAD | 5.64% |
| 2020 FY | 286.88 Thousand USD | 744.77% |
| 2020 Q1 | 74.32 Thousand CAD | 68.76% |
| 2020 Q2 | 220.92 Thousand CAD | 197.26% |
| 2020 Q4 | 365.49 Thousand CAD | 56.6% |
| 2019 Q4 | 44.03 Thousand CAD | 0.0% |
| 2019 Q1 | - CAD | -100.0% |
| 2019 FY | 33.96 Thousand USD | -65.35% |
| 2018 Q1 | 202.9 Thousand CAD | 6.85% |
| 2018 FY | 98 Thousand CAD | -35.34% |
| 2018 Q4 | 137.8 Thousand CAD | 77.59% |
| 2018 Q3 | 77.59 Thousand CAD | 0.84% |
| 2018 Q2 | 76.94 Thousand CAD | -62.08% |
| 2017 Q2 | 30 Thousand CAD | 78797.88% |
| 2017 Q1 | 38.02 CAD | -99.88% |
| 2017 FY | 151.56 Thousand CAD | 564.61% |
| 2017 Q4 | 189.9 Thousand CAD | 533.01% |
| 2017 Q3 | 30 Thousand CAD | 0.0% |
| 2016 FY | 22.8 Thousand CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | 30.58 Thousand CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q1 | - CAD | -100.0% |
| 2015 FY | - CAD | -100.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | -93.61% |
| 2014 Q4 | 25.00 CAD | -99.93% |
| 2014 Q3 | 34.5 Thousand CAD | -91.62% |
| 2014 Q2 | 411.83 Thousand CAD | 2.61% |
| 2014 Q1 | 401.35 Thousand CAD | 2.65% |
| 2013 Q1 | 95.00 CAD | 0.0% |
| 2013 Q2 | 395.00 CAD | 315.79% |
| 2013 Q3 | 395 Thousand CAD | 99900.0% |
| 2013 Q4 | 391 Thousand CAD | -1.01% |
| 2013 FY | 391 Thousand CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | 91.003% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | 32.597% |
| Össur hf. | 467.73 Million USD | 99.991% |
| QHSLab, Inc. | 1.78 Million USD | 97.73% |
| Wellstar International, Inc. | 51.36 Million USD | 99.921% |
| Össur hf. | 467.73 Million USD | 99.991% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | 92.293% |
| Aurora Spine Corporation | 2.67 Million USD | 98.486% |
| BrainsWay Ltd. | 471 Thousand USD | 91.414% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | 99.727% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 99.855% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 91.853% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | 77.294% |
| Zecotek Photonics Inc. | 3.22 Million USD | 98.745% |
| Avitar, Inc. | 5.26 Million USD | 99.232% |
| Nanomix Corporation | 11.4 Million USD | 99.645% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 99.225% |
| Theraclion SA | 1.95 Million EUR | 97.927% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | 97.738% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 97.619% |
| Lombard Medical, Inc. | 32.29 Million USD | 99.875% |
| ALR Technologies Inc. | 19.26 Million USD | 99.79% |
| Stratec SE | 156.16 Million USD | 99.974% |
| Vycor Medical, Inc. | 1.11 Million USD | 96.357% |
| Heart Tronics, Inc. | 209.28 Thousand USD | 80.676% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.998% |
| VMS Rehab Systems, Inc. | 133.52 USD | -30189.095% |
| NewCardio, Inc. | 3 Million USD | 98.652% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 98.035% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 93.592% |
| Odyssey Group International, Inc. | 2.14 Million USD | 98.114% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 93.964% |
| Wellness Center USA, Inc. | 4.04 Million USD | 98.999% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 99.873% |
| IR-Med Inc. | 161 Thousand USD | 74.881% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | 79.034% |
| Polarean Imaging plc | 216.38 Thousand USD | 81.31% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | 98.725% |
| Nu-Med Plus, Inc. | 100 Thousand USD | 59.558% |
| Capital Group Holdings, Inc. | 4944.00 USD | -718.002% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 94.943% |
| Medical Supply International USA, Inc. | 227 Thousand USD | 82.184% |
| Urologix, Inc. | 5.33 Million USD | 99.242% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 98.944% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 99.041% |
| SS Innovations International, Inc. | 8.21 Million USD | 99.508% |
| Qualis Innovations, Inc. | 9102.00 USD | -344.32% |
| Smith & Nephew plc | 3.07 Billion USD | 99.999% |
| NIOX Group Plc | 1.4 Million USD | 97.112% |
| Fuse Medical, Inc. | 1.99 Million USD | 97.971% |
| Broncus Holding Corporation | 2.35 Million USD | 98.282% |
| Brain Scientific Inc. | 2.86 Million USD | 98.588% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 99.822% |